Literature DB >> 20127702

Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.

Jean-Marc Taymans1,2, Mark R Cookson1.   

Abstract

Parkinson's disease (PD) is generally sporadic but a number of genetic diseases have parkinsonism as a clinical feature. Two dominant genes, alpha-synuclein (SNCA) and leucine-rich repeat kinase 2 (LRRK2), are important for understanding inherited and sporadic PD. SNCA is a major component of pathologic inclusions termed Lewy bodies found in PD. LRRK2 is found in a significant proportion of PD cases. These two proteins may be linked as most LRRK2 PD cases have SNCA-positive Lewy bodies. Mutations in both proteins are associated with toxic effects in model systems although mechanisms are unclear. LRRK2 is an intracellular signaling protein possessing both GTPase and kinase activities that may contribute to pathogenicity. A third protein, tau, is implicated as a risk factor for PD. We discuss the potential relationship between these genes and suggest a model for PD pathogenesis where LRRK2 is upstream of pathogenic effects through SNCA, tau, or both proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127702      PMCID: PMC4662284          DOI: 10.1002/bies.200900163

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.653


  116 in total

1.  Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.

Authors:  R A Crowther; S E Daniel; M Goedert
Journal:  Neurosci Lett       Date:  2000-10-06       Impact factor: 3.046

2.  Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

Authors:  Robert E Drolet; Bahareh Behrouz; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2004-09       Impact factor: 4.294

3.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.

Authors:  Sreeganga Chandra; Francesco Fornai; Hyung-Bae Kwon; Umar Yazdani; Deniz Atasoy; Xinran Liu; Robert E Hammer; Giuseppe Battaglia; Dwight C German; Pablo E Castillo; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

4.  How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.

Authors:  Mark R Cookson; Georgia Xiromerisiou; Andrew Singleton
Journal:  Curr Opin Neurol       Date:  2005-12       Impact factor: 5.710

5.  Identification of potential protein interactors of Lrrk2.

Authors:  Justus C Dächsel; Julie P Taylor; Su San Mok; Owen A Ross; Kelly M Hinkle; Rachel M Bailey; Jacob H Hines; Jennifer Szutu; Benjamin Madden; Leonard Petrucelli; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-04-02       Impact factor: 4.891

6.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

7.  Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Authors:  William Dauer; Nikolai Kholodilov; Miquel Vila; Anne-Cecile Trillat; Rose Goodchild; Kristin E Larsen; Roland Staal; Kim Tieu; Yvonne Schmitz; Chao Annie Yuan; Marcelo Rocha; Vernice Jackson-Lewis; Steven Hersch; David Sulzer; Serge Przedborski; Robert Burke; Rene Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

8.  Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.

Authors:  M Frasier; M Walzer; L McCarthy; D Magnuson; J M Lee; C Haas; P Kahle; B Wolozin
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

Review 9.  Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).

Authors:  Bradley F Boeve; Mike Hutton
Journal:  Arch Neurol       Date:  2008-04

Review 10.  Cell systems and the toxic mechanism(s) of alpha-synuclein.

Authors:  Mark R Cookson; Marcel van der Brug
Journal:  Exp Neurol       Date:  2007-06-04       Impact factor: 5.330

View more
  31 in total

Review 1.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

2.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Authors:  Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark R Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

3.  Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Andrew Ferree; Katelyn Smith; Eugenio Barone; Marzia Perluigi; Raffaella Coccia; William Pierce; Jian Cai; Cesare Mancuso; Rachel Squillace; Manfred Wiengele; Isabella Dalle-Donne; Benjamin Wolozin; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-03-20       Impact factor: 8.401

4.  Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Authors:  Joanna M Biernacka; Sebastian M Armasu; Julie M Cunningham; J Eric Ahlskog; Sun Ju Chung; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2011-08-03       Impact factor: 4.891

Review 5.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

Review 6.  LRRK2 Pathways Leading to Neurodegeneration.

Authors:  Mark R Cookson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 7.  Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?

Authors:  Edward D Plowey; Charleen T Chu
Journal:  Neurobiol Dis       Date:  2010-10-20       Impact factor: 5.996

8.  Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity.

Authors:  Susanne Zach; Sandra Felk; Frank Gillardon
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

Review 9.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

10.  Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration.

Authors:  Edward D Plowey; Jon W Johnson; Erin Steer; Wan Zhu; David A Eisenberg; Natalie M Valentino; Yong-Jian Liu; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2014-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.